FABP5 facilitates tumour growth by modulating key signalling pathways, such as PI3K/AKT, MAPKs, and NF-κB, particularly within inflammatory and lipid-rich tumour microenvironments mimicked by adipocyte-conditioned medium (aCM) [127]. The gene discussed is AKT1; the disease is neoplasm.